CoChat

Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review

Canhada, Scheine, Castro, Kamila, Perry, Ingrid Schweigert, Luft, Vivian Cristine · 2018 · Nutritional Neuroscience

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Alzheimer's disease (AD) is a neurodegeneration disorder characterized by progressive impairments of memory, language, reasoning, and other cognitive functions. Evidence suggests that omega-3 fatty acids may act as a possible protection factor in AD. OBJECTIVE: To evaluate the results available in the literature involving omega-3 fatty acids supplementation and its effect on cognitive function in AD patients. METHODS: A systematic review of MEDLINE (from PubMed), Excerpta Medica Database, and Cochrane Library databases was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion criteria consisted in original intervention studies, controlled by placebo, that assessed the impact of supplementation or dietary intake of omega-3 fatty acids on cognitive function, in humans with AD, without limitation for prime date of publication. RESULTS: Initial search resulted in 361 articles. Seven studies fully met the inclusion criteria. Most studies did not find statistically significant results for the omega-3 fatty acids supplementation compared to placebo, and those who show some benefit do it only in a few cognitive assessment scales. However, the effects of omega-3 fatty acids appear to be most effectively demonstrated in patients with very mild AD. CONCLUSION: The effects of omega-3 fatty acids supplementation in mild AD corroborate epidemiological observational studies showing that omega-3 fatty acids may be beneficial in disease onset, when there is slight impairment of brain function. Although some studies have shown changes in scales of cognitive function in more severe cases, they are not enough to support omega-3 fatty acids supplementation in the treatment of AD.

Overview

Integrity signals

Registry

Crossref · 10.1080/1028415x.2017.1321813

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 2

  1. Masters CL, 2016, Nat Rev Dis Prim, 1, 1
  2. 2016, Cochrane Database Syst Rev, 4, 1

Cited by

See all 171

Metadata

Authors
Canhada, S., Castro, K., Perry, I. S., & Luft, V. C.
Affiliations
  • Universidade Federal do Rio Grande do Sul (BR)
  • Food and Nutrition Research Centre (CESAN), Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Corresponding author
Canhada, Scheine
Venue
Nutritional Neuroscience
Published
2017-05-03
Volume
21
Issue
8
Pages
529-538
ISSN
  • 1028-415X (ISSN-L)
  • 1476-8305
OpenAlex
W2611431983
Cited by
156
References
35
Citations by year
2026: 12 · 2025: 16 · 2024: 23 · 2023: 15 · 2022: 20 · 2021: 17 · 2020: 27 · 2019: 14 · 2018: 7 · 2017: 4
FWCI
1.47
Type
journal article
Language
en
Open access
closed
Locations
  • Nutritional Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
omega-3 fatty acids, Alzheimer's disease, dietary supplementation, cognitive function, neurodegeneration, mild Alzheimer's disease, cognitive impairment
MeSH terms
Diet, Healthy, Alzheimer Disease, Animals, Anti-Inflammatory Agents, Non-Steroidal, Cognition, Fish Oils, Fishes, Humans, Patient Compliance, Severity of Illness Index, Reproducibility of Results, Fatty Acids, Omega-3, Seafood, Neuroprotective Agents, Nootropic Agents, Controlled Clinical Trials as Topic, Evidence-Based Medicine, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review. https://app.cochat.ai/papers/10.1080/1028415x.2017.1321813
The paper
Canhada, S., Castro, K., Perry, I. S., & Luft, V. C. (2018). Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review. Nutritional Neuroscience. https://doi.org/10.1080/1028415x.2017.1321813

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.